Ruiwen Shi,Patrick M. Hughes,James A. Burke,Michael R. Robinson,Hui Liu
申请号:
US14482039
公开号:
US20150104491A1
申请日:
2014.09.10
申请国别(地区):
US
年份:
2015
代理人:
摘要:
The present invention provides a sustained release implant for intraocular use to treat elevated intraocular pressure, which implant is configured for intracameral or anterior vitreal administration to a patient with elevated intraocular pressure (IOP), said implant comprising a core of an antihypertensive agent surrounded by a polymer, which limits the rate of passage of the antihypertensive agent from the implant into the eye of said patient and said implant provides a linear rate of release of therapeutically effective amounts of said anti-hypertensive agent into the eye for a period of time of between 14 days and 365 days.